Behandlingsinstitutionen Curam ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  39.8% 38.0% 13.7% 12.3% 6.3%  
Credit score (0-100)  1 0 15 18 37  
Credit rating  C C BB BB BBB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  460 2,566 3,451 2,123 3,914  
EBITDA  -926 -1,456 211 61.0 1,241  
EBIT  -975 -1,545 122 -28.0 1,133  
Pre-tax profit (PTP)  -1,007.6 -1,685.8 120.0 -67.0 1,032.9  
Net earnings  -786.6 -1,964.8 120.0 -67.0 1,032.9  
Pre-tax profit without non-rec. items  -1,008 -1,686 120 -67.0 1,033  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  374 285 196 108 192  
Shareholders equity total  -941 -2,906 -2,786 -3,259 -2,226  
Interest-bearing liabilities  0.0 0.0 0.0 2,991 2,621  
Balance sheet total (assets)  809 727 869 814 1,522  

Net Debt  0.0 -79.5 -185 2,923 2,443  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  460 2,566 3,451 2,123 3,914  
Gross profit growth  0.0% 458.2% 34.5% -38.5% 84.4%  
Employees  0 0 6 1 6  
Employee growth %  0.0% 0.0% 0.0% -83.3% 500.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  809 727 869 814 1,522  
Balance sheet change%  164.3% -10.2% 19.6% -6.3% 87.0%  
Added value  -926.4 -1,456.1 210.9 60.9 1,241.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  282 -178 -178 -177 -24  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 -3.0 1.0 -1.0 1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -212.2% -60.2% 3.5% -1.3% 28.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -88.2% -57.4% 3.3% -0.6% 29.3%  
ROI %  -4,091.2% -1,281.3% 126.0% -1.5% 40.9%  
ROE %  -141.1% -255.9% 15.0% -8.0% 88.4%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -53.8% -80.0% -76.2% -85.4% -69.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 5.5% -87.6% 4,791.8% 196.8%  
Gearing %  0.0% 0.0% 0.0% -91.8% -117.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 3.0% 4.1%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.2 0.1 0.1 0.1 0.3  
Current Ratio  0.2 0.1 0.1 0.1 0.3  
Cash and cash equivalent  0.0 79.5 184.8 68.0 177.4  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -1,423.5 -3,153.5 -3,138.1 -3,523.0 -2,646.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 35 61 207  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 35 61 207  
EBIT / employee  0 0 20 -28 189  
Net earnings / employee  0 0 20 -67 172